Annora Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANNORA PHARMA, and what generic and branded alternatives to ANNORA PHARMA drugs are available?
ANNORA PHARMA has thirty-four approved drugs.
There are five tentative approvals on ANNORA PHARMA drugs.
Summary for Annora Pharma
US Patents: | 0 |
Tradenames: | 28 |
Ingredients: | 28 |
NDAs: | 34 |
Patent Litigation for Annora Pharma: | See patent lawsuits for Annora Pharma |
Drugs and US Patents for Annora Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annora Pharma | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 215939-001 | Jan 11, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | DIVALPROEX SODIUM | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 215527-001 | Sep 26, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 212475-002 | Sep 10, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | GLYCOPYRROLATE | glycopyrrolate | SOLUTION;ORAL | 213698-001 | Jul 5, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 215939-003 | Jan 11, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 212475-001 | Sep 10, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.